Skip to main content
. 2020 Feb 22;116(4):856–870. doi: 10.1093/cvr/cvaa006

Figure 3.

Figure 3

ACCF/AHA/ACP/AATS/PCNA/SCAI/STS stable ischaemic heart disease guidelines. Colours respond to the class of recommendations in the ACCF/AHA. The algorithms do not represent a comprehensive list of recommendations. The use of bile acid sequestrant is relatively contraindicated when triglycerides are ≥200 mg/dL and is contraindicated when triglycerides are ≥500 mg/dL. Dietary supplement niacin must not be used as a substitute for prescription niacin. ACCF, American College of Cardiology Foundation; ACE-I, angiotensin-converting enzyme inhibitor; AHA, American Heart Association; ARB, angiotensin-receptor blocker; ASA, aspirin; ATP III, Adult Treatment Panel 3; BP, blood pressure; CCB, calcium channel blocker; CKD, chronic kidney disease; HDL-C, high density lipoprotein cholesterol; JNC VII, Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure; LDL-C, low density lipoprotein cholesterol; LV, left ventricular; MI, myocardial infarction; NHLBI, National Heart, Lung and Blood Institute; NTG, nitroglycerine.